Offer commercial strategy and planning support for biotechnology companies. Services include situation assessments, market opportunities, competitive intelligence, portfolio/brand strategy, and launch preparation. Therapeutic areas supported include neurology, oncology, and rare disease.

Recruited to stabilize sales team during launch of Doptelet for Liver Disease indication while responsible for preparing, building, and directing a high performing sales team for the launch of 2nd indication in Immune thrombocytopenic purpura (ITP), a hematologic autoimmune rare disease. Developed and executed launch strategy and go-to market plan, as a member of core leadership team. Accountable for P & L.
Built team of 70 including Territory Business Managers and Regional Directors.

First team member in a pre-commercialization role as the US Commercial Launch Lead for Selonsertib and NASH portfolio forecasted to be a multibillion-dollar product and first product launch in a ~30-billion-dollar market. Responsible for the development, and implementation of commercial strategy, launch plan and execution for Subpart H approval.

Hepatitis B Promotions team leader responsible for Viread HBV and the launch of Vemlidy. Managed team of 5 marketers accountable for HCP, DTP and Market Development strategies and tactics. Spearheaded the creation and execution of commercial launch plan, readiness process, and strategy for Vemlidy

Lead and Managed a specialty sales team

Focused on field-based market development strategy and activities.

Specialty Sales

Multiple Sales roles